CEA-targeted CAR-T cell therapy

CAR-T cell therapy targeting carcinoembryonic antigen (CEA) · Chongqing Precision Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEA-targeted CAR-T cell therapy, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer [Phase 1]

See pricing